A small, non-toxic molecule may soon be available as an inexpensive treatment for many forms of cancer, including lung, breast and brain tumours, say University of Alberta researchers.
But there's a catch: the drug isn't patented, and pharmaceutical companies may not be interested in funding further research if the treatment won't make them a profit.
You can almost hear the sneer associated with that dirty profit word can't you?
But profit isn't the problem here - the problem is the prohibitively expensive approval process that pharmaceuticals have to go through to get drugs to market.
If a drug company could get a drug to market without spending a billion dollars in research they would be falling over themselves to bring a non-toxic cancer drug to market.
So before you complain about those greedy drug companies remember that they can only make money by helping people - its the government that is preventing them from doing so.